Progressive	progressive	O	O
myopathy	myopathy	O	S_disease
with	with	O	O
up-regulation	up-regulation	O	O
of	of	O	O
MHC-I	mhc-i	S_chemicals	O
associated	associated	O	O
with	with	O	O
statin	statin	S_chemicals	O
therapy	therapy	O	O
.	.	O	O

Statins	statins	S_chemicals	O
can	can	O	O
cause	cause	O	O
a	a	O	O
necrotizing	necrotizing	O	S_disease
myopathy	myopathy	O	S_disease
and	and	O	O
hyperCKaemia	hyperckaemia	O	O
which	which	O	O
is	is	O	O
reversible	reversible	O	O
on	on	O	O
cessation	cessation	O	O
of	of	O	O
the	the	O	O
drug	drug	S_chemicals	O
.	.	O	O

What	what	O	O
is	is	O	O
less	less	O	O
well	well	O	O
known	known	O	O
is	is	O	O
a	a	O	O
phenomenon	phenomenon	O	O
whereby	whereby	O	O
statins	statins	S_chemicals	O
may	may	O	O
induce	induce	O	O
a	a	O	O
myopathy	myopathy	O	S_disease
,	,	O	O
which	which	O	O
persists	persists	O	O
or	or	O	O
may	may	O	O
progress	progress	O	O
after	after	O	O
stopping	stopping	O	O
the	the	O	O
drug	drug	S_chemicals	O
.	.	O	O

We	we	O	O
investigated	investigated	O	O
the	the	O	O
muscle	muscle	O	O
pathology	pathology	O	S_disease
in	in	O	O
8	8	O	O
such	such	O	O
cases	cases	O	O
.	.	O	O

All	all	O	O
had	had	O	O
myofibre	myofibre	O	O
necrosis	necrosis	O	S_disease
but	but	O	O
only	only	O	O
3	3	O	O
had	had	O	O
an	an	O	O
inflammatory	inflammatory	O	O
infiltrate	infiltrate	O	O
.	.	O	O

In	in	O	O
all	all	O	O
cases	cases	O	O
there	there	O	O
was	was	O	O
diffuse	diffuse	O	O
or	or	O	O
multifocal	multifocal	O	S_disease
up-regulation	up-regulation	O	O
of	of	O	O
MHC-I	mhc-i	S_chemicals	O
expression	expression	O	O
even	even	O	O
in	in	O	O
non-necrotic	non-necrotic	O	O
fibres	fibres	O	O
.	.	O	O

Progressive	progressive	O	O
improvement	improvement	O	O
occurred	occurred	O	O
in	in	O	O
7	7	O	O
cases	cases	O	O
after	after	O	O
commencement	commencement	O	O
of	of	O	O
prednisolone	prednisolone	S_chemicals	O
and	and	O	O
methotrexate	methotrexate	S_chemicals	O
,	,	O	O
and	and	O	O
in	in	O	O
one	one	O	O
case	case	O	O
spontaneously	spontaneously	O	O
.	.	O	O

These	these	O	O
observations	observations	O	O
suggest	suggest	O	O
that	that	O	O
statins	statins	S_chemicals	O
may	may	O	O
initiate	initiate	O	O
an	an	O	O
immune-mediated	immune-mediated	O	O
myopathy	myopathy	O	S_disease
that	that	O	O
persists	persists	O	O
after	after	O	O
withdrawal	withdrawal	O	O
of	of	O	O
the	the	O	O
drug	drug	S_chemicals	O
and	and	O	O
responds	responds	O	O
to	to	O	O
immunosuppressive	immunosuppressive	O	O
therapy	therapy	O	O
.	.	O	O

The	the	O	O
mechanism	mechanism	O	O
of	of	O	O
this	this	O	O
myopathy	myopathy	O	S_disease
is	is	O	O
uncertain	uncertain	O	O
but	but	O	O
may	may	O	O
involve	involve	O	O
the	the	O	O
induction	induction	O	O
by	by	O	O
statins	statins	S_chemicals	O
of	of	O	O
an	an	O	O
endoplasmic	endoplasmic	O	O
reticulum	reticulum	O	O
stress	stress	O	O
response	response	O	O
with	with	O	O
associated	associated	O	O
up-regulation	up-regulation	O	O
of	of	O	O
MHC-I	mhc-i	S_chemicals	O
expression	expression	O	O
and	and	O	O
antigen	antigen	S_chemicals	O
presentation	presentation	O	O
by	by	O	O
muscle	muscle	O	O
fibres	fibres	O	O
.	.	O	O

